Peptide record

TPDB11093

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
29 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11093
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP Peptipedia Antifungipept CAFPdb HemoPI Hemolytic2
standard
No
A 29-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GFMDTAKNVAKNVAVTLLDNLKCKITKAC
Physicochemical Analysis
C135H233N37O40S3
REQHPSWY
K
3110.74
9.65
5
2
13
+3
4.80
0.203
97.59
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
4.02
8
Residue Composition
number
4
A
0
R
3
N
2
D
2
C
0
E
0
Q
1
G
0
H
1
I
3
L
5
K
1
M
1
F
0
P
0
S
3
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 4 R: 0 N: 3 D: 2 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 3 K: 5 M: 1 F: 1 P: 0 S: 0 T: 3 W: 0 Y: 0 V: 3
Chemical Descriptors
29
C135H233N37O40S3
3110.74
9.65
+3
4.80
0.203
Evidence Records 11 records
Evidence 1 Activity

Activity

MIC
Antibacterial
64-128 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

S.aureus ATCC 29213

Source & Reference

dbAMP

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
64-128 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
>128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
>128 µg/mL

Target

S.aureus ATCC 29213

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
64-128 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 8 Activity

Activity

MIC
Antiparasitic
>128 µg/mL

Target

S.enteritidis

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
>128 µg/mL

Target

S.aureus ATCC 29213

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64-128 ug/ml), S.enteritidis (MIC >128 ug/ml), and S.aureus ATCC 29213 (MIC >128 ug/ml).
Evidence 10 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects | Antibiotics (Basel) | 2022
Evidence 11 Hemolysis

Source & Reference

HemoPI
NA